AdaptHealth to Elect Declassified Board, Details Executive Compensation with Strong Pay-for-Performance Alignment
AHCO sits 69% above its 52-week low of $7.91.
Summary
AdaptHealth Corp. filed its definitive proxy statement for its annual meeting, proposing the election of a fully declassified board and detailing executive compensation, which includes significant annual bonuses and the forfeiture of prior performance-based equity awards due to underperformance.
Key Events · Corporate Governance and Compliance · AHCO
-
Board Declassification Completed
All nine directors will now be elected annually for one-year terms, enhancing corporate governance and accountability.
-
Executive Compensation Aligned with Performance
2025 annual cash bonuses for NEOs paid out at 116.22% of target, reflecting strong achievement of financial metrics (Net Revenue, Adjusted EBITDA, Free Cash Flow).
-
Prior Performance Equity Forfeited
Performance-vested stock units (PSUs) granted in 2022 and 2023 resulted in a 0% payout due to the company's Total Shareholder Return (TSR) falling below threshold relative to peers, underscoring a rigorous pay-for-performance model.
-
Director Not Renominated
Diana Nole's term will expire at the 2026 Annual Meeting as she was not renominated for election.
Analysis · AHCO · Industrial Applications And Services
The filing highlights key corporate governance enhancements, including the completion of board declassification, ensuring all directors will now serve one-year terms, which generally improves accountability. Executive compensation for 2025 shows a strong link between pay and performance, with annual cash bonuses for named executive officers (NEOs) paying out at 116.22% of target based on Net Revenue, Adjusted EBITDA, and Free Cash Flow. Crucially, performance-vested restricted stock units (PSUs) granted in 2022 and 2023 were forfeited (0% payout) due to the company's Total Shareholder Return (TSR) falling below threshold levels relative to peers. This demonstrates a robust pay-for-performance philosophy where long-term incentives are genuinely at risk and align with shareholder outcomes. Investors should note the company's commitment to these governance and compensation practices, especially in light of the previously reported net loss for 2025.
How filings like this one have moved
In the 30 days to Sep 17, 2026, 29.6% of the 1742 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.35%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, AHCO was trading at $13.38 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $1.8B. The 52-week trading range was $7.91 to $13.39. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.